TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06426342

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: metaverse-based blended online intervention
Description: A new metaverse-based blended online intervention was developed using an online program and coaching via metaverse to prevent depression among Generation MZ Employees in South Korea.
Study: NCT05847192

Intervention type: DIAGNOSTIC_TEST
Intervention: [18F]-PI2620 PET scan
Description: The PET scan will measure the regional distribution of tau aggregation in AD patients with and without psychosis compared to Cognitively Unimpaired Healthy participants with the PET radiotracer \[18F\]-PI2620.

Intervention type: DIAGNOSTIC_TEST
Intervention: [18F]-PI2620 PET scan
Description: The PET scan will measure the regional distribution of tau aggregation in AD patients with and without psychosis compared to Cognitively Unimpaired Healthy participants with the PET radiotracer \[18F\]-PI2620.

Intervention type: DIAGNOSTIC_TEST
Intervention: [18F]-PI2620 PET scan
Description: The PET scan will measure the regional distribution of tau aggregation in AD patients with and without psychosis compared to Cognitively Unimpaired Healthy participants with the PET radiotracer \[18F\]-PI2620.
Study: NCT04531410

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: linoleic acid supplementation
Description: Oils given daily at morning meal with extra enzymes

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: oleic acid supplementation
Description: Oils given at morning meal with extra enzymes
Study: NCT05760898

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blood pressure intervention arm
Description: The intervention will focus on empowering patients to actively participate in their HTN care, facilitating patient-provider communication, and creating a cohesive care team to close the coordination loop for HTN management. This pilot intervention will help achieve these goals by providing participants with home blood pressure monitors and teaching, improving patient-provider communication regarding blood pressure and RA management, and initiating care coordination between rheumatology and primary care providers.
Study: NCT05759728

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CNA3103: 5 x 10^7 cells
Description: CNA3103: 5 x 10\^7 cells - intravenous infusion
Study: NCT05925361

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic pedicled single flap peritoneum vaginoplasty
Description: After the perineal part of the operation, in which the vaginal cavity will be dissected, a laparoscopy will be started. During laparoscopy, a single flap peritoneum will be harvested. The flap will be checked for adequate blood supply. The flap will be brought down to the (neo) vaginal cavity and sutured around a dilatator cylinder wise.
Study: NCT05759728

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CNA3103: 1.5 x 10^8 cells
Description: CNA3103: 1.5 x 10\^8 cells - intravenous infusion

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CNA3103: 4.5 x 10^8 cells
Description: CNA3103: 4.5 x 10\^8 cells - intravenous infusion

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CNA3103: 1.5 x 10^9 cells
Description: CNA3103: 1.5 x 10\^9 cells - intravenous infusion

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CNA3103: 2.5 x 10^7 cells
Description: CNA3103: 2.5 x 10\^7 cells - intravenous infusion
Study: NCT05520203

Intervention type: OTHER
Intervention: Care provided by the Nurse Practitioner
Description: Introduction of a Nurse Practitioner in the interdisciplinary care team

Intervention type: OTHER
Intervention: Care provided by the Nurse Practitioner
Description: Introduction of a Nurse Practitioner in the interdisciplinary care team

Intervention type: OTHER
Intervention: Care provided by the Nurse Practitioner
Description: Introduction of a Nurse Practitioner in the interdisciplinary care team
Study: NCT04797585

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic supracervical hysterectomy
Description: Laparoscopic supracervical hysterectomy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy
Description: Vaginal hysterectomy
Study: NCT05750823

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib Cream
Description: Ruxolitinib cream will be applied twice daily for upto 48 weeks
Study: NCT06570447

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glofitamab
Description: For Glofitamab Injection solution, after Obinutuzumab pretreatment on Day 1 of Cycle 1, patients followed a step-dose escalation regimen.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide
Description: Chidamide: 30 mg/d orally twice a week for 21 days as a treatment cycle.
Study: NCT06502483

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Promoting Resilience in Stress Management Program
Description: Promoting Resilience in Stress Management (PRISM; Rosenberg et al., 2018; Rosenberg et al., 2021) is is an evidence-based skills-based resilience intervention. In the current study, PRISM sessions with be facilitated by a trained mental health provider to equip participants with skills for coping with anxiety, low mood, and adjustment to cancer diagnosis and to target four resilience resources (i.e., stress management, goal setting, cognitive reframing, and meaning-making). Sessions will be conducted by phone or Zoom, a HIPAA-compliant telemedicine platform. The optional mPRISM phone application includes 6 modules to practice PRISM skills and is available for iOS/Android.
Study: NCT06537700

Intervention type: DRUG
Intervention: OnabotulinumtoxinA OBT-A
Description: Patients will be re-evaluated every 3 months, at each OBT-A cycle, during the whole year of treatment. Every evaluation patients will show their diary of headaches with monthly migraine and headache days and acute medications taken.
Study: NCT05449418

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Full Intervention
Description: A small group of employees who work at facilities randomized to this arm will be invited to develop tailored COVID-19 vaccination promotion materials in teams with other long-term care staff sharing the same or similar language and/or cultural affinity. These employees will also help promote these materials to all of the employees who work at their facilities.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Employees who work at facilities randomized to this arm will see COVID-19 vaccine promotion materials from the Centers for Disease Control and Prevention \[CDC\] or other national organization.
Study: NCT06646614

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group Advance Care Planning Education
Description: Those assigned to the group ACP arm will participate in a virtual or in-person session every 4 weeks (2 sessions total) led by a trained health educator who is a staff member. Sessions will introduce advanced care planning, help veterans determine their goals of care and learn how to raise this with their oncologist, and discuss creating or updating an advanced directive. Participants will be surveyed and interviewed to learn about their satisfaction with 1:1 and group advance care planning education and their degree of activation in care by a research staff member.
Study: NCT06569901

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hope Intervention
Description: Group meetings after hospital discharge reflecting on themes that may have an impact on hope.~The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hope Intervention
Description: Group meetings after hospital discharge reflecting on themes that may have an impact on hope.~The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hope Intervention
Description: Group meetings after hospital discharge reflecting on themes that may have an impact on hope.~The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hope Intervention
Description: Group meetings after hospital discharge reflecting on themes that may have an impact on hope.~The Hope Intervention consists of four group meetings and two individual conversations during a four week period.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hope Intervention
Description: Group meetings after hospital discharge reflecting on themes that may have an impact on hope.~The Hope Intervention consists of four group meetings and two individual conversations during a four week period.
Study: NCT06154291

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XON7
Description: The trial intervention (XON7) is a glyco-humanized polyclonal antibody drug which is formulated for intravenous (IV) administration
Study: NCT06005467

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation of mandibular angle fracture using V shaped plate
Description: its a new plate that have been used in fixation of fractures in various areas of the mandible,V shaped plate was used in the treatment of three angle fracture cases which provided the advantage of including both lines of osteosynthesis which are the superior border and the lateral surface of the external oblique ridge using one plate.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open reduction and internal fixation of mandibular angle fracture using V shaped plate
Description: its a new plate that have been used in fixation of fractures in various areas of the mandible,V shaped plate was used in the treatment of three angle fracture cases which provided the advantage of including both lines of osteosynthesis which are the superior border and the lateral surface of the external oblique ridge using one plate.
Study: NCT06328686

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Arginine
Description: Given IV or PO

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Arginine
Description: Given IV or PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spectroscopy
Description: Undergo spectroscopy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spectroscopy
Description: Undergo spectroscopy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Whole-Brain Radiotherapy
Description: Undergo WBRT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Whole-Brain Radiotherapy
Description: Undergo WBRT
Study: NCT06446453

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Echography-guided Surfactant THERapy (ESTHER)
Description: Decision to administer surfactant therapy using a semi-quantitative lung ultrasound score.
Study: NCT04865627

Intervention type: DEVICE
Intervention: activity monitor
Description: Both groups will wear three different activity monitors for one week. There is one observation moment which consists of four minutes lying, sitting, standing, walking and taking stairs. Participants will be filmed during this moment.

Intervention type: DEVICE
Intervention: activity monitor
Description: Both groups will wear three different activity monitors for one week. There is one observation moment which consists of four minutes lying, sitting, standing, walking and taking stairs. Participants will be filmed during this moment.
Study: NCT04382950

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid
Description: In this study, the experimental group will receive 0.4 mg/kg rbACE2 IV plus Aerosolized 13 cis retinoic acid in gradual in 2 divided doses increases froms 0.2 mg/kg/day to 4 mg/kg/day as inhaled 13 cis retinoic acid therapy for 14 days
Study: NCT04570371

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conversation Guide + Clinical Support
Description: The intervention is a bundled intervention (conversation guide + clinician decision support tools) which promotes the solicitation and use of patient preferences for post-surgical, non-pharmacological pain management strategies.
Study: NCT06301490

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release
Description: Myofascial release is a popular hands-on method manual therapy technique that uses carefully guided low load, long duration mechanical pressures to modify the myofascial complex (directly or indirectly), with the goal of restoring appropriate length, decreasing discomfort, and improving range of motion, muscle recovery, and physical performance in healthy persons.
Study: NCT05682430

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Heart rate based HIIT
Description: Week1,90% HRmax long duration HIIT + 90% HRmax long duration HIIT. Week2,90% HRmax long duration HIIT + 90% long duration HRmax HIIT. Week3,90% HRmax long duration HIIT + 90% HRmax long duration HIIT. Week4,90% HRmax long duration HIIT + 90% HRmax long duration HIIT. Week5,90% HRmax short duration HIIT + 90～95% HRmax long duration HIIT. Week6,90% HRmax short duration HIIT + 90～95% HRmax long duration HIIT. Week7,90% HRmax short duration HIIT + 90～95% HRmax long duration HIIT. Week8,90% HRmax short duration HIIT + 90～95% HRmax long duration HIIT. Week9,90～95% HRmax short duration HIIT + 90～95% HRmax short duration HIIT. Week10,90～95% HRmax short duration HIIT + 90～95% HRmax short duration HIIT. Week11,90～95% HRmax short duration HIIT + 90～95% HRmax short duration HIIT. Week12,90～95% HRmax short duration HIIT + 90～95% HRmax short duration HIIT.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VIFT speed-based HIIT with mechanical work
Description: Week1,Wednesday 65% VIFT HIIT, saturday 65% VIFT HIIT. Week2,Wednesday 65% VIFT HIIT, saturday 65% VIFT HIIT. Week3,Wednesday 67.5% VIFT HIIT, saturday 67.5% VIFT HIIT. Week4,Wednesday 67.5% VIFT HIIT, saturday 67.5% VIFT HIIT. Week5,Wednesday 70% VIFT HIIT, saturday 90% VIFT HIIT. Week6,Wednesday 70% VIFT HIIT, saturday 90% VIFT HIIT. Week7,Wednesday 72.5% VIFT HIIT, saturday 92.5% VIFT HIIT. Week8,Wednesday 72.5% VIFT HIIT, saturday 92.5% VIFT HIIT. Week9,Wednesday 92.5% VIFT HIIT, saturday 100% VIFT HIIT. Week10,Wednesday 92.5% VIFT HIIT, saturday 100% VIFT HIIT. Week11,Wednesday 95% VIFT HIIT, saturday 105% VIFT HIIT. Week12,Wednesday 95% VIFT HIIT, saturday 105% VIFT HIIT.
Study: NCT05195502

Intervention type: DIAGNOSTIC_TEST
Intervention: Biopsy
Description: Participants included in the study, will have additional biopsies performed during their colonoscopy
Study: NCT04997473

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: W8L2G mobile health (mHealth) app
Description: Weight loss phone app based on addiction principles. This intervention has been validated in two prior studies. Participants will also interact with coaches throughout the intervention
Study: NCT05142852

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Description: The participants in the experiment group received 5 consecutive sessions of ESWT for 5 minutes. Treatment parameters for the shock wave therapy group were set similar to a previous study (Devrimsel et al., 2013) 2000 shock waves with 1.6 bar intensity and 16 Hz frequency were applied for five sessions using the Swiss DolorClast Master (EMS, Nyon, Switzerland). All participants used 10-cm lateral epicondyle bandages in the treatment period, while none of them received analgesic or anti-inflammatory drugs and received exercise programs.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: The participants in the control group received 5 sessions of conventional physical therapy intervention for 5 minutes. The control group intervention consists of a 1-minute friction massage over the common extensor tendon of the elbow, followed by 3 minutes therapeutic ultrasound with a frequency of 1.5 Hz, and a 1-minute ice massage over the common extensor tendon of the elbow. All participants used 10-cm lateral epicondyle bandages in the treatment period, while none of them received analgesic or anti-inflammatory drugs and received exercise programs.
Study: NCT04721535

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWJ1248
Description: Orally, 1 tablet of DWJ1248 TID, up to 14 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Orally, 1 tablet of placebo TID, up to 14 days
Study: NCT05741359

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
Description: CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
Study: NCT06476756

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ACTIVE CYCLE OF BREATHING TECHNIQUE
Description: Group A: combine effects of ACBT and Buteyko techniques will be performed first 3days of cardiac rehab phase 1.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Buteyko techniques
Description: Group B: effect of buteyko techniques will be performed first three days of cardiac rehab phase 1.
Study: NCT06221995

Intervention type: DIAGNOSTIC_TEST
Intervention: Indirect Calorimetry
Description: Resting energy expenditure measurement
Study: NCT06474767

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: P-CGS (Pediatric Collaborative Goal Setting)
Description: Electronic questionnaire sent to participants ahead of a pediatric primary care well child visit, assessing goals for themselves and the child's health with prompt to share with providers during visit
Study: NCT05764265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LTP001
Description: LTP001 will be administered orally once daily in the morning
Study: NCT06503263

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zanubrutinib plus Lenalidomide as Maintenance Therapy
Description: Patients were treated by Zanubrutinib(160mg po bid d1-28) plus Lenalidomide(25mg po qd d1-14) as maintenance therapy until 2 years post chemotherpay
Study: NCT06284382

Intervention type: OTHER
Group type: OTHER
Intervention: High score at Childhood Trauma Questionnaire.
Description: In the presence of early trauma arm, 15 participants are recruited based on a high Childhood Trauma Questionnaire total score.

Intervention type: OTHER
Group type: OTHER
Intervention: Low score at Childhood Trauma Questionnaire.
Description: In the absence of early trauma arm, 15 participants are recruited based on a low Childhood Trauma Questionnaire total score.
Study: NCT05495789

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: A relaxing video will be watched with virtual reality glasses.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: Relaxing music will be played by wearing headphones.
Study: NCT05679388

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relugolix Pill
Description: A medication used to treat prostate cancer. Relugolix comes as a tablet to take by mouth. It is usually taken with or without food once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relugolix Pill
Description: A medication used to treat prostate cancer. Relugolix comes as a tablet to take by mouth. It is usually taken with or without food once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relugolix Pill
Description: A medication used to treat prostate cancer. Relugolix comes as a tablet to take by mouth. It is usually taken with or without food once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relugolix Pill
Description: A medication used to treat prostate cancer. Relugolix comes as a tablet to take by mouth. It is usually taken with or without food once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relugolix Pill
Description: A medication used to treat prostate cancer. Relugolix comes as a tablet to take by mouth. It is usually taken with or without food once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Description: HIV antiviral It can treat HIV infection, which causes AIDS. It does not cure HIV or AIDS, but combinations of drugs may slow the progress of the disease and prolong life.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Description: HIV antiviral It can treat HIV infection, which causes AIDS. It does not cure HIV or AIDS, but combinations of drugs may slow the progress of the disease and prolong life.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: A drug used to treat fungal infections.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: A drug used to treat fungal infections.
Study: NCT05981235

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AZD6422 CLDN18.2 CAR-T product
Description: AZD6422 CAR-T product infusion after pre-conditioning
Study: NCT05697328

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine Pill
Description: One-time 60mg dose given orally between 45-120 minutes prior to hyperbaric oxygen therapy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One time dose given orally between 45-120 minutes prior to hyperbaric oxygen therapy
Study: NCT06318468

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing health assessment teaching and discussion using humanoid diagrams
Description: The experimental group will receive the nursing health assessment teaching for 50 minutes and discussion using humanoid diagrams for 40 minutes to learn comprehensive nursing assessment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nursing health assessment teaching and discussion using case study
Description: The comparison group will receive the nursing health assessment teaching for 50 minutes and discussion using case study for 40 minutes to learn comprehensive nursing assessment.
Study: NCT06046118

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Yellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)
Description: Each session consists of:~* 1st phase: 300 seconds of continuous Yellow light (eyes closed) + 60 seconds of pulsed Yellow light (eyes opened)~* 2nd phase: 300 seconds of continuous Red light(eyes closed) + 60 seconds of pulsed Red light (eyes opened).~Cycle 1: 8 sessions (two PBM per week for 4 weeks); Cycle 2: 6 sessions (two PBM per week for 3 weeks).

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Mask
Description: Low light emission mask (Sham Mask, Espansione group, Bologna, Italy)